Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco Vera-Badillo

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of the National Cancer Institute|August 19, 2015
ResponseAlberto Ocana, Francisco Vera-Badillo, Arnoud Templeton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2013
Phase III trials of targeted anticancer therapies: redesigning the conceptAlberto Ocana, Eitan Amir, Francisco Vera-Badillo, et al.
Journal of the National Cancer Institute|December 11, 2012
HER3 overexpression and survival in solid tumors: a meta-analysisAlberto Ocana, Francisco Vera-Badillo, Bostjan Seruga, et al.
World Journal of Urology|February 19, 2017
Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based studyD Robert Siemens, Melanie T Jaeger, Xuejiao Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysisSaroj Niraula, Eitan Amir, Francisco Vera-Badillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trialIsabelle Boutron, Douglas G Altman, Sally Hopewell, et al.
Cancer Treatment Reviews|June 15, 2013
Fulvestrant for advanced breast cancer: a meta-analysisMustafa Al-Mubarak, Adrian G Sacher, Alberto Ocana, et al.
Breast Cancer Research and Treatment|September 8, 2012
Management of small HER2 overexpressing tumoursArnoud Templeton, Alberto Ocaña, Boštjan Seruga, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2015
Influence of censoring on conclusions of trials for women with metastatic breast cancerArnoud J Templeton, Olga Ace, Eitan Amir, et al.
Future Science OA|December 20, 2017
Duration of suppression of bone turnover following treatment with zoledronic acid in men with metastatic castration-resistant prostate cancerSaroj Niraula, Arnoud J Templeton, Francisco Vera-Badillo, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute|August 19, 2015
ResponseAlberto Ocana, Francisco Vera-Badillo, Arnoud Templeton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2013
Phase III trials of targeted anticancer therapies: redesigning the conceptAlberto Ocana, Eitan Amir, Francisco Vera-Badillo, et al.
Journal of the National Cancer Institute|December 11, 2012
HER3 overexpression and survival in solid tumors: a meta-analysisAlberto Ocana, Francisco Vera-Badillo, Bostjan Seruga, et al.
World Journal of Urology|February 19, 2017
Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based studyD Robert Siemens, Melanie T Jaeger, Xuejiao Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysisSaroj Niraula, Eitan Amir, Francisco Vera-Badillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trialIsabelle Boutron, Douglas G Altman, Sally Hopewell, et al.
Cancer Treatment Reviews|June 15, 2013
Fulvestrant for advanced breast cancer: a meta-analysisMustafa Al-Mubarak, Adrian G Sacher, Alberto Ocana, et al.
Breast Cancer Research and Treatment|September 8, 2012
Management of small HER2 overexpressing tumoursArnoud Templeton, Alberto Ocaña, Boštjan Seruga, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2015
Influence of censoring on conclusions of trials for women with metastatic breast cancerArnoud J Templeton, Olga Ace, Eitan Amir, et al.
Future Science OA|December 20, 2017
Duration of suppression of bone turnover following treatment with zoledronic acid in men with metastatic castration-resistant prostate cancerSaroj Niraula, Arnoud J Templeton, Francisco Vera-Badillo, et al.
Pageof 3